期刊文献+

HPLC/ESI-MS测定减肥保健食品中的双去甲基西布曲明 被引量:12

Determination of N-di-Desmethylsibutramine with HPLC/ESI-MS in Slimming Health Food Products
原文传递
导出
摘要 目的建立高效液相色谱质谱联用技术(HPLC/ESI—MS)的测定方法,测定保健食品中双去甲基西布曲明。方法色谱条件为Johnson SpherigelC18色谱柱(4.6mm×250mm,5μm);流动相:流动相A液(0.25%乙酸+20mmol/L乙酸铵),流动相B液(甲醇)=25+75(体积比),流速1mL/min,检测波长223nm。质谱采用电喷雾正离子模式(ESI+),分子离子峰m/z252。结果双去甲基西布曲明在0.01~1.20mg/ml范围内,浓度与峰面积呈良好的线性关系,最低检出限为0.95μg/ml(S/N=3)。结论本方法流动相简单,分析时间短且试样预处理简单,灵敏度高,借助质谱的定性能力,可大大提高方法可靠性和抗干扰能力,能准确快速地测定保健食品中的双去甲基西布曲明。 Objective A high-performance liquid chromatography electrospray/mass spectrometry (HPLC/ESI-MS) method was developed to detect N-di-desmethylsibutramine in slimming health food products. Method The separation was completed on a RP-C18 column (4.6 mm × 250 mm, 5 μm) with 0.25% acetic acid aqueous solution containing 20 mmmol/L ammonium acetate as mobile phase. Elution run at a flow rate of 1 ml/min and UV detection was performed at 223 nm. Results Good linearity was shown between the peak area and the concentration of N-di-desmethylsibutramine standards, in a range of 0. 01-1.20 mg/ml. Conclusion The correlation coefficient of the calibration curves was better than O. 9997 ( n = 6). The limit of detection (LOD) was 0.95 μg/ml ( S/N= 3 ). The method was sensitive, precise and highly reproducible.
作者 陈稚 吴都督
出处 《中国食品卫生杂志》 北大核心 2010年第1期24-26,共3页 Chinese Journal of Food Hygiene
基金 广东医学院青年基金资助项目(xq06027)
关键词 液相色谱-电喷雾质谱联用 双去甲基西布曲明 保健食品 减肥药 High-Performance Liquid Chromatography Electrospray/Mass Spectrometry N-di-Desmethylsibutramine Health Food Anti-Obesity Agents
  • 相关文献

参考文献2

  • 1CHEN Jun, LU Wei, ZHANG Qizhi, et al. Determination of the active metabolite of sibutramine by liquid chromatographyelectrospray ionization tendem mass spectrometry [ J ] . J Chromatography B, 2003, 785 (2): 197-203. 被引量:1
  • 2左晓春,笪宏远.新一代减肥药──西布曲明[J].中国临床药理学杂志,2000,16(2):155-157. 被引量:27

二级参考文献10

  • 1Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects (abstract)[].Journal of Clinical Pharmacology.1995 被引量:1
  • 2Drouin P,Hanotin C,Courciers,et al.A dose-ranging study efficacy andtolerability of sibutramine in weight loss[].Int J Ohes.1994 被引量:1
  • 3Study number SB 1049,Federal Drug Administration New Drug Approvalpackge [on-line]. http://w.w.w.fda gov cder /foi /ida /index 97 htm . 1998 被引量:1
  • 4.Meridia (sibutramine hydrolride monohydrate)Product information knollpharmaceutical conpany[]..1997 被引量:1
  • 5Bach DS,Rissanen AM,Mendel CM et.al.Absence of cardiac valvedysfunction in obese patients treated with sibutrsmine[].International Journal of Obesity.1998 被引量:1
  • 6Silverstone T.Appetitie suppressants:a review[].Drugs.1992 被引量:1
  • 7Bray,G.A.,Ryan,D.H.,Gordon,D.A double-blind randomized placebo-controlled trial of sibutramine[].Obesity Research.1996 被引量:1
  • 8Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects(abstract)[].Journal of Clinical Pharmacology.1995 被引量:1
  • 9Luscombe GP,Hopcroft RH,Thomas PC,et al.The contribution ofmetabolites to the rapid and potent down-regulation of rat conical betaadrenoceptors by the putative antidepressant sibutramine hydrochloride[].Neuropharmacology.1989 被引量:1
  • 10Weintraub M.Rubio A,Golik A,et.al .Sibutramine in weight control: adose-ranging,efficacy study[].Clinical Pharmacology and Therapeutics.1991 被引量:1

共引文献26

同被引文献140

引证文献12

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部